Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double‐blind, placebo control clinical trial

Ejemplares similares

• A double‐blind, randomized, placebo‐controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females
  por: B. H. Mullish, et al.
  Publicado: (2024)
• Randomized double‐blind placebo‐controlled study to evaluate the effect of long‐acting mesalamine on postinfectious irritable bowel syndrome with diarrhea
  por: Ashok K. Tuteja, et al.
  Publicado: (2024)
• Predictors of irritable bowel syndrome‐like symptoms in quiescent inflammatory bowel disease
  por: Mehwish Ahmed, et al.
  Publicado: (2024)
• Differences in provider recommendations for Black/African American and White patients with irritable bowel syndrome
  por: Taylor Boyd, et al.
  Publicado: (2024)
• Effect of reboxetine and citalopram on anal opening pressure in healthy women: A randomized, double‐blind, placebo‐controlled crossover study
  por: Thea Christoffersen, et al.
  Publicado: (2024)